Danaher Corporation acquired Abcam plc for approximately $5.6 billion cash purchase price ($24.00 per share), a transaction completed in December 2023, structured as all cash.
Abcam plc operates in Life Sciences (protein consumables), is based in Cambridge, United Kingdom. Danaher acquired Abcam plc in December 2023 for ~$5.6 billion; Abcam is a leading global supplier of protein consumables, including highly validated antibodies, reagents, biomarkers and assays addressing targets in biological pathways.
Added to Danaher's Life Sciences segment, providing additional sales and earnings opportunities in the proteomics sector.
On December 6, 2023, the Company acquired Abcam plc (“Abcam”) for a cash purchase price of approximately $5.6 billion (the “Abcam Acquisition”). Abcam is a leading global supplier of protein consumables, including highly validated antibodies, reagents, biomarkers and assays to address targets in biological pathways.Danaher Corporation FY23 10-K, acquisition note
Advisory firms were not disclosed for this transaction.